1. 5-Hydroxypyrido[2,3-b]pyrazin-6(5H)-one Derivatives as Novel Dual Inhibitors of HIV-1 Reverse Transcriptase-associated Ribonuclease H and Integrase. Sun, L., P. Gao, G.Y. Dons, X.J. Zhang, X.Q. Cheng, X. Ding, X.S. Wang, D. Daelemans, E. De Clercq, C. Pannecouque, L. Menendez-Arias, P. Zhan, and X.Y. Liu. European Journal of Medicinal Chemistry, 2018. 155: p. 714-724. PMID[29940462].
[PubMed]. HIV_09_2018.
2. 6-Arylthio-3-hydroxypyrimidine-2,4-diones Potently Inhibited HIV Reverse Transcriptase-associated RNase H with Antiviral Activity. Wang, L., J. Tang, A.D. Huber, M.C. Casey, K.A. Kirby, D.J. Wilson, J. Kankanala, J.S. Xie, M.A. Parniak, S.G. Sarafianos, and Z.Q. Wang. European Journal of Medicinal Chemistry, 2018. 156: p. 652-665. PMID[30031976]. PMCID[PMC6112573].
[PubMed]. HIV_09_2018.
3. 6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones Potently and Selectively Inhibited HIV Reverse Transcriptase-associated RNase H. Wang, L., J. Tang, A.D. Huber, M.C. Casey, K.A. Kirby, D.J. Wilson, J. Kankanala, M.A. Parniak, S.G. Sarafianos, and Z.Q. Wang. European Journal of Medicinal Chemistry, 2018. 156: p. 680-691. PMID[30031978]. PMCID[PMC6114935].
[PubMed]. HIV_09_2018.
4. Chemical System Biology Based Molecular Interactions to Identify Inhibitors against Q151M Mutant of HIV-1 Reverse Transcriptase. Pandey, R.K., D. Sharma, R. Ojha, T.K. Bhatt, and V.K. Prajapati. Infection Genetics and Evolution, 2018. 63: p. 5-12. PMID[29753024].
[PubMed]. HIV_09_2018.
5. Graphene Quantum Dots Based Systems as HIV Inhibitors. Iannazzo, D., A. Pistone, S. Ferro, L. De Luca, A.M. Monforte, R. Romeo, M.R. Buemi, and C. Pannecouque. Bioconjugate Chemistry. 29(9): p. 3084-3093. PMID[30106563].
[PubMed]. HIV_09_2018.
6. Identification, Structural Modification, and Dichotomous Effects on Human Immunodeficiency Virus Type 1 (HIV-1) Replication of Ingenane Esters from Euphorbia kansui. Liu, Q.B., W. Li, L. Huang, Y. Asada, S.L. Morris-Natschke, C.H. Chen, K.H. Lee, and K. Koike. European Journal of Medicinal Chemistry, 2018. 156: p. 618-627. PMID[30031972].
[PubMed]. HIV_09_2018.
7. N-6-Methyladenosine-binding Proteins Suppress HIV-1 Infectivity and Viral Production. Lu, W.X., N. Tirumuru, C. St Gelais, P.C. Koneru, C. Liu, M. Kvaratskhelia, C. He, and L. Wu. Journal of Biological Chemistry, 2018. 293(34): p. 12992-13005. PMID[29976753]. PMCID[PMC6109920].
[PubMed]. HIV_09_2018.
8. Nuclear Pore Heterogeneity Influences HIV-1 Infection and the Antiviral Activity of MX2. Kane, M., S.V. Rebensburg, M.A. Takata, T.M. Zang, M. Yamashita, M. Kvaratskhelia, and P.D. Bieniasz. eLife, 2018. 7: e35738. PMID[30084827]. PMCID[PMC6101944].
[PubMed]. HIV_09_2018.
9. Synthesis and Antiviral Evaluation of TriPPPro-AbacavirTP, TriPPPro-CarbovirTP, and Their 1',2'-cis-Disubstituted Analogues. Weising, S., V. Sterrenberg, D. Schols, and C. Meier. ChemMedChem. 13(17): p. 1771-1778. PMID[29943432].
[PubMed]. HIV_09_2018.
Patent Citations
This month, no relevant HIV patents were identified.